المؤلفون: Jo, Jae-Hyun, Park, Jong-Uk, Kim, Yeong-Mu, Ok, Seon-Mi, Kim, Dong-Kyu, Jung, Dong-Hyun, Kim, Hye-Ji, Seong, Hyun-A, Cho, Hyo Je, Nah, Jihoon, Kim, Sangjune, Fu, Haiqing, Redon, Christophe E., Aladjem, Mirit I., Jang, Sang-Min^{Aff1, IDs12964023012466_cor15}

المصدر: Cell Communication and Signaling. 21(1)

المؤلفون: Jae-Hyun Jo, Jong-Uk Park, Yeong-Mu Kim, Seon-Mi Ok, Dong-Kyu Kim, Dong-Hyun Jung, Hye-Ji Kim, Hyun-A Seong, Hyo Je Cho, Jihoon Nah, Sangjune Kim, Haiqing Fu, Christophe E. Redon, Mirit I. Aladjem, Sang-Min Jang

المصدر: Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-12 (2023)

مصطلحات موضوعية: Megakaryocytic differentiation, RepID, CRL4A, JARID1A, Medicine, Cytology, QH573-671

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1478-811X

URL الوصول: https://doaj.org/article/491ba279b8ea4325a3b65829219d8458

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bai N; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA. Electronic address: nbai@amgen.com., Riching KM; Research and Development Department, Promega Corporation, Madison, Wisconsin, USA. Electronic address: Kristin.Riching@promega.com., Makaju A; Discovery Attribute Science, Amgen Research, South San Francisco, California, USA., Wu H; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Acker TM; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Ou SC; Discovery Attribute Science, Amgen Research, Thousand Oaks, California, USA., Zhang Y; Oncology, Amgen Research, Thousand Oaks, California, USA., Shen X; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Bulloch DN; Discovery Attribute Science, Amgen Research, South San Francisco, California, USA., Rui H; Discovery Attribute Science, Amgen Research, Thousand Oaks, California, USA., Gibson BW; Discovery Attribute Science, Amgen Research, South San Francisco, California, USA., Daniels DL; Research and Development Department, Promega Corporation, Madison, Wisconsin, USA., Urh M; Research and Development Department, Promega Corporation, Madison, Wisconsin, USA., Rock BM; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Humphreys SC; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA. Electronic address: shumph01@amgen.com.

المصدر: The Journal of biological chemistry [J Biol Chem] 2022 Apr; Vol. 298 (4), pp. 101653. Date of Electronic Publication: 2022 Jan 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

مواضيع طبية MeSH: Models, Molecular* , Ubiquitin-Protein Ligases*/chemistry , Ubiquitin-Protein Ligases*/metabolism , Ubiquitination*, HEK293 Cells ; Humans ; Protein Structure, Tertiary ; Proteolysis ; Ubiquitin/metabolism